Browder Capital Fund IV Secures $30 Million Backed By Sequoia Capital And Others

Browder Capital, founded by Joshua Browder, has recently announced the launch of its $30 million Fund IV, supported by prominent backers such as Sequoia Capital, Marc Andreessen, Chris Dixon, and notable figures like Arthur Patterson (founder of Accel) and Walter Kortschak (founder of Signalfire). Additionally, top institutional investors like Cendana, General Endowment Management, and Hummingbird Ventures are backing the fund. Browder, who took the Thiel Fellowship in 2018 after dropping out of Stanford, has a unique journey into investing. His first notable investment was in the startup Owner, led by Adam Guild, at the pre-seed, which has now soared to a $1 billion valuation after its Series C. Fund IV will focus on identifying and backing undiscovered talent with the potential to build billion-dollar companies from the ground up. FUND NAME: Browder Capital Fund IV INVESTORS: Sequoia Capital, Marc Andreessen Chris Dixon, Arthur Patterson, Walter Kortschak, Cendana, General Endowment Management, Level, Hummingbird Ventures (Nomads) & Slipstream AMOUNT: $30,000,000 HQ: #SanFrancisco #California #VentureCapital #BrowderCapital #JoshuaBrowder #SequoiaCapital #TradedPartner #MarcAndreessen #ChrisDixon #ArthurPatterson #WalterKortschak #Cendana #GeneralEndowmentManagement #Level #HummingbirdVentures #Nomads #Slipstream #TradedVC

More Deals

View All

Colossal Biosciences In Talks For Funding Round Targeting $23 Billion ValuationColossal Biosciences, the de-extinction biotech startup known for its efforts to recreate the woolly mammoth and other extinct species, is reportedly in talks to raise new funding at a valuation of roughly $23 billion–$24 billion, according to Axios. The potential raise would mark a significant jump for the five-year-old company, with investors valuing not only its genetic-engineering programs but also its broader genomics, reproductive technology, conservation, and intellectual property platform. Colossal has begun generating revenue through conservation technology sales and technology spinouts, including Astromech, an AI-driven predictive modeling company, and Form Bio, a computational biology platform, expanding its value beyond de-extinction efforts. FOUNDERS: Ben Lamm & George Church TARGET VALUATION: $23,000,000,000 HQ: Dallas, Texas #VentureCapital #ColossalBiosciences #BenLamm #GeorgeChurch #TradedVC